LeMaitre to Participate at Upcoming Investor Conferences in March BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March. Leerink Partners Global Healthcare ConferenceTuesday, March 10, 2026W South Beach, MiamiManagement will present at 1:00 PM EDT Citizens Life Sciences ConferenceWednesday, March 11, 2026Eden Roc Miami Beach, MiamiManagement will present at 1:40 PM EDT Barclays Annual Global Healthcare ConferenceThursday, March 12, 2026Management wil...
LeMaitre Q4 2025 Financial Results BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance. Q4 2025: Sales $64.5mm, +16% (+15% organic) vs. Q4 2024Gross margin 71.7% (+240 bps)Op. income $18.8mm (+47%)Op. margin 29%Diluted EPS $0.68 (+39%)Cash up $16.1mm sequentially to $359.1mm Grafts (+27%), valvulotomes (+20%), and carotid shunts (+18%) drove Q4 sales growth. EMEA sales increased 29%, ...
Moody's Ratings (Moody's) assigned a Aa3 rating to the new senior unsecured notes issuance of Abbott Laboratories (Abbott). In addition, we assigned a (P)Aa3 senior unsecured shelf registration. Abbott's existing ratings remain unchanged, and the outlook remains unchanged at stable. Abbott will us...
Roper Technologies announces dividend SARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that its Board of Directors has approved a dividend of $0.91 per share payable on April 22, 2026 to stockholders of record on April 6, 2026. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled produ...
Hawkins, Inc. to Participate in Raymond James & Associates’ Annual Institutional Investor Conference ROSEVILLE, Minn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Raymond James & Associates’ 47th Annual Institutional Investors Conference on March 3rd and 4th, 2026 in Orlando, Florida. The Raymond James Institutional Investors Conference provides an annual forum for portfolio manager...
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the li...
A director at Lamb Weston Holdings Inc bought 50,000 shares at 48.647USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
A director at Roper Technologies Inc bought 1,400 shares at 358.460USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.